Leprosy drug Clofazimine broadly inhibits coronavirus including SARS-CoV-2
Clofazimine, an anti-leprosy drug with a favourable safety profile, possesses pan-coronaviral inhibitory activity, and can antagonize SARS-CoV-2 and MERS-CoV replication in multiple in vitro systems.
Image by Steve Buissinne from Pixabay
** This post was originally published on March 20, 2021 **
Related Posts:
